Tag: mayne pharma

The ASX-listed drugs manufacturer announced on Wednesday it had signed a 20-year supply and licence agreement with Belgium-based Mithra Pharmaceuticals to commercialise a “next generation” contraceptive pill. Seeking a bigger slice of an American market deemed to be worth $US5.4 billion, Mayne Pharma will pay up to $US295 million ($A440 million) in cash and shares if net…